Dimed (PNVL3) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
31 Aug, 2026Executive summary
Q2 2024 was marked by severe floods in Rio Grande do Sul, impacting over 80 stores, the main distribution center, and more than 1,500 employees, causing significant operational and financial disruptions, yet retail gross revenue grew 11.5% year-over-year to R$1,178M.
Net income for Q2 was R$20.1M (1.6% margin), with adjusted EBITDA at R$49.0M (4.0% margin), both down year-over-year due to extraordinary flood-related expenses.
Market share in the Southern Region increased for the 17th consecutive quarter, with digital channels accounting for 19.1% of retail sales and app sales growing 31.5% year-over-year.
Rapid recovery: all administrative offices reopened in 40 days, lab resumed production in 60 days, and all affected stores reopened in 70 days.
Maintained strong engagement with associates and communities, delivering BRL 2 million in donations and sustaining high NPS scores.
Financial highlights
Group gross revenue reached R$1,224M (+4.9% vs 2Q23); retail gross revenue R$1,178M (+11.5% vs 2Q23); wholesale sales dropped 59.6% due to halted operations.
Adjusted EBITDA was R$49.0M (4.0% margin), with all direct flood impacts (BRL 15.2 million) fully recognized in the quarter.
Adjusted net profit was R$20.1M (1.6% margin), maintaining one of the widest adjusted margins in pharma retail.
Free cash flow was positive in Q2, reaching R$23.2M (+90% vs 2Q23), and net debt/EBITDA ended at 0.89x, the lowest in the industry.
Retail gross margin was 29.8%, pressured by aggressive discounts, higher COGS, and supply chain disruptions.
Outlook and guidance
Guidance reaffirmed for 60 new store openings in 2024, with 40 planned for H2 and 30 already signed for 2025.
Expecting 15–17% revenue growth in H2 2024, with July already showing 15% growth and record digital participation (21.2%).
Margins expected to recover as flood-related pressures subside and operational leverage improves.
Continued focus on operational leverage, logistics efficiency, and expense control.
Management considers flood impacts as seasonal and expects normalization in the following quarters.
Latest events from Dimed
- Retail revenue up 17%, digital sales at 21.2%, net income up 37.1%, and market share gains.PNVL3
Q3 2024 - Record retail revenue and digital growth drove higher profitability despite severe flood impacts.PNVL3
Q4 2024 - Net revenue rose 15% and digital sales surged, driving margin and profit growth in H1 2026.PNVL3
Q2 2026 - Gross revenue up 15.8%, EBITDA up 25.6%, and digital sales surged 45.7% in 1Q26.PNVL3
Q1 2026 - Retail revenue up 17%, digital sales up 46.8%, and EBITDA up 21.4% in 2025.PNVL3
Q4 2025 - Disciplined omnichannel growth, proprietary brands, and digital innovation drive sustained value.PNVL3
Investor presentation - Retail revenue up 14.3%, digital and private label surged, EBITDA and cash flow strong.PNVL3
Q3 2025 - Retail revenue up 19.6%, EBITDA up 42.9%, with digital and private label driving strong growth.PNVL3
Q2 2025 - Retail revenue up 15.9% YoY, digital sales surged 35.3%, and market share expanded in the South.PNVL3
Q1 2025